|
| News |
|
|
|
10.01.2009 | Thursday VDxI Launches Blood Test for the Detection of Sepsis in Dogs |
SIMI VALLEY, Calif.--(BUSINESS WIRE)—Oct 1,
2009—Veterinary Diagnostics Institute, Inc., (VDxI) a Veterinary
Clinical Ventures Company dedicated to the introduction of innovative
biomarkers for companion animals, announces the launch of VDxI pCNP;
the first and only test to detect clinically important infections such
as sepsis in canines. The pCNP test detects N-terminal C-type
natriuretic peptide...
more
|
06.01.2009 | Monday VDxI moves to larger facility |
SIMI VALLEY, CA - On June 1, 2009, VDxI moved from the Irvine
location to it's new larger facility in Simi Valley, located
approximately 40 miles northwest of downtown Los Angeles, reports the
companies founder & president, Randy Ringold.
"Our operation was growing rapidly and our existing space wasn't
accommodating to the business and our future growth plans," Ringold
explained. "With multiple biomarkers...
more
|
02.10.2009 | Tuesday VDxI and the Comparative Internal Medicine Laboratory at the MU College of Veterinary Medicine collaborate in the development of biomarker assay for sepsis |
IRVINE, CA - Veterinary Diagnostics Institute(tm) (VDxI) announces it
has entered into ongoing clinical studies with Dr. Amy DeClue and the
Comparative Internal Medicine Laboratory at the University of Missouri
College of Veterinary Medicine for the development of a biomarker
assay for detection of canine and feline sepsis. The biomarker assay
will be used to detect concentrations of the peptide NT-proCNP...
more
|
12.18.2008 | Thursday Exclusive license agreement with Colorado State University Research Foundation (CSURF) and NeoTREX™ |
IRVINE, CA - Veterinary Diagnostics Institute(tm) (VDxI) today
entered into an exclusive license agreement with Colorado State
University Research Foundation (CSURF) and NeoTREX(tm) of Fort
Collins, CO for development of a biomarker assay for detection of
canine hemangiosarcoma.
The technology, co-invented by faculty at CSU's Animal Cancer
Center (a member of CSU's Cancer Supercluster) and investigators
at...
more
|
|
|